Skip to content

Clinical trials

Observational Ocular Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Observational Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20031
20041
20051
20066
20073
20084
20098
20108
20116
20126
20135
20144
20153
20163
20171
20182
20192
20206
20216
20222
20231
20247
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66
Unknown status14
Recruiting7
Terminated5
Active, not recruiting4
Not yet recruiting3
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan21
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.7
Alcon Research4
National Eye Institute (NEI)3
University of Colorado, Denver3
Aston University2
Glaukos Corporation2
Guy's and St Thomas' NHS Foundation Trust2
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA2
St. Erik Eye Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension103
Glaucoma, Open-Angle60
Glaucoma56
Exfoliation Syndrome6
Low Tension Glaucoma4
Cataract3
Eye Diseases3
Glaucoma, Angle-Closure3
Hypertension2
Keratoconus2

Trials

Showing 76 to 100 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.